These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32521162)

  • 41. Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells.
    Benguigui M; Weitz IS; Timaner M; Kan T; Shechter D; Perlman O; Sivan S; Raviv Z; Azhari H; Shaked Y
    Sci Rep; 2019 Aug; 9(1):12613. PubMed ID: 31471546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.
    Tao Z; Muzumdar MD; Detappe A; Huang X; Xu ES; Yu Y; Mouhieddine TH; Song H; Jacks T; Ghoroghchian PP
    Nano Lett; 2018 Apr; 18(4):2195-2208. PubMed ID: 29533667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
    Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
    Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
    Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
    Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer.
    Wu Y; Tang Y; Xie S; Zheng X; Zhang S; Mao J; Wang B; Hou Y; Hu L; Chai K; Chen W
    Theranostics; 2020; 10(3):1151-1165. PubMed ID: 31938057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells.
    Sanna V; Nurra S; Pala N; Marceddu S; Pathania D; Neamati N; Sechi M
    J Med Chem; 2016 Jun; 59(11):5209-20. PubMed ID: 27139920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein-bound polysaccharide decreases invasiveness and proliferation in pancreatic cancer by inhibition of hedgehog signaling and HIF-1α pathways under hypoxia.
    Onishi H; Morisaki T; Nakao F; Odate S; Morisaki T; Katano M
    Cancer Lett; 2013 Jul; 335(2):289-98. PubMed ID: 23485726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
    Sakai S; Iwata C; Tanaka HY; Cabral H; Morishita Y; Miyazono K; Kano MR
    J Control Release; 2016 May; 230():109-15. PubMed ID: 27080571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
    Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
    Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nano-sensitizer with self-amplified drug release and hypoxia normalization properties potentiates efficient chemoradiotherapy of pancreatic cancer.
    Yu S; Jiang Y; Li Q; Li M; Su J; Lai S; Gan Z; Ding Z; Yu Q
    Biomaterials; 2024 Oct; 310():122634. PubMed ID: 38823195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.
    Zhao J; Wang H; Hsiao CH; Chow DS; Koay EJ; Kang Y; Wen X; Huang Q; Ma Y; Bankson JA; Ullrich SE; Overwijk W; Maitra A; Piwnica-Worms D; Fleming JB; Li C
    Biomaterials; 2018 Mar; 159():215-228. PubMed ID: 29331808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
    PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of fatty acid oxidation supports pancreatic cancer growth and survival under hypoxic conditions through autophagy induction.
    Kim B; Gwak J; Kim M; Yang S; Hwang S; Shin S; Kim JH; Son J; Jeong SM
    Cancer Gene Ther; 2023 Jun; 30(6):878-889. PubMed ID: 36807391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
    Lu T; Prakash J
    Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.